BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17973579)

  • 1. [HFE gene mutations and risk of hepatocellular carcinoma].
    Solís Herruzo JA; Solís Muñoz P
    Rev Esp Enferm Dig; 2007 Jul; 99(7):369-75. PubMed ID: 17973579
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE gene in primary and secondary hepatic iron overload.
    Sebastiani G; Walker AP
    World J Gastroenterol; 2007 Sep; 13(35):4673-89. PubMed ID: 17729389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
    Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
    J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE mutations in insulin resistance-associated hepatic iron overload.
    Guillygomarc'h A; Mendler MH; Moirand R; Jouanolle AM; David V; Deugnier Y
    J Hepatol; 2000 Sep; 33(3):515-6. PubMed ID: 11020014
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?
    Ioannou GN; Kowdley KV
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):246-8. PubMed ID: 15017663
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
    Bonkovsky HL; Obando JV
    Curr Gastroenterol Rep; 1999; 1(1):30-7. PubMed ID: 10980924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload.
    Fargion S; Valenti L; Fracanzani AL
    Hepatology; 2010 Apr; 51(4):1119-21. PubMed ID: 20373367
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron overload and chronic hepatitis C: the role of HFE gene mutations.
    García Buey L; González Mateos F
    Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003
    [No Abstract]   [Full Text] [Related]  

  • 12. HFE gene mutation, chronic liver disease, and iron overload In Turkey.
    Yönal O; Hatirnaz O; Akyüz F; Ozbek U; Demir K; Kaymakoglu S; Okten A; Mungan Z
    Dig Dis Sci; 2007 Nov; 52(11):3298-302. PubMed ID: 17410459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic iron loading in patients with compound heterozygous HFE mutations.
    Lim EM; Rossi E; De Boer WB; Reed WD; Jeffrey GP
    Liver Int; 2004 Dec; 24(6):631-6. PubMed ID: 15566515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
    Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
    Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.
    Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C
    Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].
    Ropero P; Briceño O; López-Alonso G; Agúndez JA; González Fernández FA; García-Hoz F; Villegas Martínez A; Díaz-Rubio M; Ladero JM
    Rev Esp Enferm Dig; 2007 Jul; 99(7):376-81. PubMed ID: 17973580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemochromatosis gene mutation in hepatocellular cancer.
    Willis G; Wimperis JZ; Lonsdale R; Jennings BA
    Lancet; 1997 Aug; 350(9077):565-6. PubMed ID: 9284787
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
    Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
    Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the HFE gene (H63D and C282Y) mutations in patients with iron overload, family members and controls from Antioquia, Northwest Colombia.
    Avila-Gomez IC; Latorre-Sierra G; Restrepo-Gutierrez JC; Correa-Arango G; Jimenez-Del-Rio M; Velez-Pardo C
    Clin Genet; 2008 Jan; 73(1):92-3. PubMed ID: 18005180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.